Ilan Ganot - 27 Jan 2023 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role: Director
Signature: /s/ by David Tyrone Howton as attorney-in-fact for Ilan Ganot
Issuer symbol: SLDB
Transactions as of: 27 Jan 2023
Net transactions value: -$11,407
Form type: 4
Filing time: 31 Jan 2023, 20:17:17 UTC
Previous filing: 05 Jan 2023
Next filing: 06 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SLDB	Common Stock	Options Exercise		+388	+34%		1,519	27 Jan 2023	Wife	F1, F2
transaction	SLDB	Common Stock	Sale	$1,056	-141	-9.3%	$7.49	1,378	27 Jan 2023	Wife	F3
transaction	SLDB	Common Stock	Options Exercise		+3,883	+4.7%		85,973	27 Jan 2023	Direct	F1, F4
transaction	SLDB	Common Stock	Sale	$10,351	-1,382	-1.6%	$7.49	84,591	27 Jan 2023	Direct	F3, F5
holding	SLDB	Common Stock						19,394	27 Jan 2023	See Footnote	F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SLDB	Restricted Stock Units	Options Exercise	$0	-388	-25%	$0.000000	1,165	27 Jan 2023	Common Stock	388		Wife	F1, F7
transaction	SLDB	Restricted Stock Units	Options Exercise	$0	-3,883	-25%	$0.000000	11,650	27 Jan 2023	Common Stock	3,883		Direct	F1, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	Includes 1,462 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on November 30, 2022.
F3	This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).
F4	Includes 490 shares of common stock and 1,462 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2022 and November 30, 2022, respectively.
F5	Represents 81,931 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.
F6	Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.
F7	On January 27, 2022 (the "Grant Date"), Ms. Ganot was granted 1,553 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.
F8	On the Grant Date, the reporting person was granted 15,533 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.